- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT05689567
Focus-outbril op emmetropisatie bij Chinese kinderen
Effect van perifere focus-outbril op emmetropisatie bij Chinese kinderen van 6-8 jaar: 2 jaar gerandomiseerde klinische studie.
The purpose of this study is to characterize the effects of peripheral focous-out glasses on emmetropization in non-myopic Chinese Children Aged 6-8 Years.This is a prospective, parallel-controlled randomized trial.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Myopia is one of the most common eye diseases that cause visual impairment and blindness, and the high rate of myopia in young people is a major public health issue. Based on the clinical studies of optical defocusing to regulate eye growth and refractive changes through visual signal feedback, we hypothesize that early wearing of peripheral defocus glasses in children can slow down the process of emmetropization and even prevent the onset of myopia by producing more myopic defocusing. The aim of this study is to investigate whether wearing peripheral defocus glasses can effectively delay emmetropization in non-myopic children aged 6-8 years , and to further explore its effect on preventing the onset of myopia.
The study adopts a 2-year,single-centre, randomized, parallel-controlled trial with a non-blinded design. Subjects who pass the screening period will have their baseline data collected and will be assigned to the experimental or control groups according to the randomization principle. The experimental group will be fitted with Direct Emmetropia with Focus-out Glasses (hereafter referred to as DEFOG) to guide the emmetropization process. The control group will be given no treatment and will be a blank control. Baseline data including visual acuity, cycloplegic objective refraction, axis length, accommodation amplitude, strabismus examination, pupil size, choroidal thickness and peripheral retinal refraction will be measured when enrolled in the group and follow-up data will be measured at month 6, 12, 18 and 24. The primary interest of this study will be studied by comparing the difference in cycloplegic objective refraction changes between month 24 and baseline in the two groups of subjects.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, China, 201110
- Children's Hospital of Fudan University
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Age: ≥6 and ≤8 years at enrollment.
- At least one parent' s Spherical equivalent refraction≤-3.00D.
- Spherical equivalent refractions (SERs) under cycloplegia: +0.50 to +1.50 diopters (D)
- Astigmatism ≤1.00 D .
- Anisometropia ≤1.00 D.
- Best Corrected Visual Acuity (BCVA) : 1.0 or better
- Provision of consent written by subject's legal guardian
- Willing and able to participate in all required activities of the study
Exclusion Criteria:
- Any of the following abnormalities on the ocular surface, such as trachoma, pemphigoid, chemical injury, heat burn, radiation injury, etc.
- Eyelid abnormalities (e.g. entropion, ectropion, tumor, edema, blepharospasm, incomplete eyelid closure, severe trichiasis, severe ptosis) ,which affect eyelid function in either eye
- Eye diseases such as strabismus, amblyopia, anisometropia, fundus diseases, and accommodation abnormality,etc.
- Prior treatment of myopia control in either eye, including but not limited to drugs, orthokeratology, low-level red-light therapy, etc.
- Noncompliance with measurement at enrollment.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: DEFOG group
Subjescts will wear DEFOG glasses(peripheral focus-out glasses). |
Subjects in the intervention group will wear peripheral focus-out glasses ≧8 hours a day and ≧5 days a week. |
|
Geen tussenkomst: Control group
Subjects in the control group will just be observed. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Overall Changes of Cycloplegic Objective Refraction(spherical equivalent refraction, SER)(D)
Tijdsspanne: From baseline till the 24th month
|
Changes of cycloplegic objective refraction(i.e reflected by SER) from baseline till the 24th month (only the right-eye data included). Objective refraction data will be examined by AUTO REF/KERATOMETER. Ciliary muscle paralysis will be performed by using 1% cyclopentanone eye drops, 2 doses in each eye, 2 doses 5 minutes apart. The optometry will be performed after 20 minutes of complete ciliary muscle paralysis (disappearance of pupil response to light or pupil diameter at least greater than 6 mm). SER is calculated by adding the sum of the sphere power with half of the cylinder power. Baseline data will be measured at the time of enrollment. Follow-up data will be measured on the 24th month from baseline. The 24th month data will be subtracted from the baseline data to obtain changes. |
From baseline till the 24th month
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Changes of Cycloplegic Objective Refraction(SER) (D)
Tijdsspanne: The 6th month, the 12th month and the 18th month from baseline
|
Changes of cycloplegic objective refraction (i.e reflected by SER) different follow-up time and the baseline time (only the right-eye data included). Objective refraction data will be examined by AUTO REF/KERATOMETER. |
The 6th month, the 12th month and the 18th month from baseline
|
|
Myopia
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Cycloplegic SER≦-0.50D at any follow-up time. Objective refraction data will be examined by AUTO REF/KERATOMETER. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Changes of Axial Length(AL)(mm)
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Changes of Axial Length (AL) between different follow-up time and the baseline time (only the right-eye data included).AL will be examined by IOL Master. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Amplitude of Accommodation (AMP)(D)
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Amplitude of Accommodation (AMP) at any follow-up time (only the right-eye data included). AMP will be examined by lens test. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Uncorrected Visual Acuity
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
The Logarithmic Visual Acuity at any follow-up time (only the right-eye data included). |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Strabismus Examination(△)
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Strabismus examination at any follow-up time by SYNOPTOPHORE. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Changes of Choroidal Thickness (ChT) (um)
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Changes of Choroidal Thickness (ChT)between different follow-up time and the baseline time (only the right-eye data included). ChT will be examined by OPTICALCOHERENCETOMOGRAPHY. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Pupil size(mm)
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Pupil size at any follow-up time (only the right-eye data included). |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Peripheral Retinal Refraction(D)
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Peripheral Retinal Refraction at any follow-up time (only the right-eye data included). Peripheral Retinal Refraction will be examined by AUTO FUNDUS CAMERA. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
The percentage of participants with fast myopic shift
Tijdsspanne: From baseline till the 24th month
|
The percentage of participants with fast myopic shift over 2 years(only the right-eye data included). The fast myopic shift is defined as cycloplegic objective refraction (i.e reflected by SER) myopic shift of at least 1.00 D. Objective refraction data will be examined by AUTO REF/KERATOMETER. |
From baseline till the 24th month
|
|
Corneal curvature(D) or radius of curvature(mm)
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Corneal curvature or radius of curvature(only the right-eye included). They can be interconverted. Data will be examined by AUTO REF/KERATOMETER. |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
|
Astigmatism (D)
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
The adtigmatism at any follow-up time (only the right-eye data included). |
The 6th month, the 12th month, the 18th month and the 24th month from baseline
|
Medewerkers en onderzoekers
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- DEFOG
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .